DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported a first-quarter loss of $157.8 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Dublin-based company said it had a loss of $2.82. Earnings, adjusted for one-time gains and costs, were 45 cents per share.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 66 cents per share.
The drugmaker posted revenue of $534.7 million in the period, which also did not meet Street forecasts. Seven analysts surveyed by Zacks expected $538.4 million.
Jazz expects full-year earnings in the range of $11.25 to $12.50 per share, with revenue in the range of $2.12 billion to $2.26 billion.
Jazz shares have dropped 26% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $110.41, a drop of 17% in the last 12 months.